Status:
COMPLETED
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
Lead Sponsor:
Xanodyne Pharmaceuticals
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.
Eligibility Criteria
Inclusion
- 18-65 years of age
- Have undergone bunionectomy surgery
- Have achieved adequate post-surgical pain
Exclusion
- Confounding medical conditions which preclude study participation
- Participated in a study of another investigational drug or device within 30 days prior to randomization
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00375934
Start Date
September 1 2006
Last Update
September 21 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigative Site
Austin, Texas, United States, 78705
2
Investigative Site
Houston, Texas, United States, 77057
3
Investigative Site
San Marcos, Texas, United States, 78666
4
Investigative Site
Salt Lake City, Utah, United States, 84117